Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapy.
Traynor R, Vignola I, Sarkar S, Prochazkova M, Cai Y, Shi R, Underwood S, Ramanujam S, Yates B, Silbert S, Jin P, Dreyzin A, Shah NN, Somerville RP, Stroncek DF, Song HW, Highfill SL.
Traynor R, et al. Among authors: jin p.
Cytotherapy. 2024 Dec 8:S1465-3249(24)00939-3. doi: 10.1016/j.jcyt.2024.11.013. Online ahead of print.
Cytotherapy. 2024.
PMID: 39652017
Free article.